6.53
+0.0073(+0.11%)
Currency In USD
| Previous Close | 6.52 |
| Open | 6.5 |
| Day High | 6.6 |
| Day Low | 6.37 |
| 52-Week High | 7.18 |
| 52-Week Low | 3.21 |
| Volume | 1.21M |
| Average Volume | 4.28M |
| Market Cap | 1.57B |
| PE | -27.2 |
| EPS | -0.24 |
| Moving Average 50 Days | 5.06 |
| Moving Average 200 Days | 4.9 |
| Change | 0.01 |
If you invested $1000 in Ardelyx, Inc. (ARDX) 10 years ago, it would be worth $1,274.86 as of September 08, 2025 at a share price of $6.527. Whereas If you bought $1000 worth of Ardelyx, Inc. (ARDX) shares 5 years ago, it would be worth $4,410.34 as of September 08, 2025 at a share price of $6.527.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ardelyx Announces Changes to the Executive Leadership Team
GlobeNewswire Inc.
Aug 04, 2025 8:08 PM GMT
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSW
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire Inc.
Jul 21, 2025 12:00 PM GMT
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer
GlobeNewswire Inc.
Jun 02, 2025 8:05 PM GMT
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs